Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Top HIV/AIDS drugs worldwide based on revenue 2016-2018

Selected top HIV/AIDS drugs worldwide based on revenue from 2016 to 2018 (in million U.S. dollars)

by Matej Mikulic, last edited Sep 19, 2019
Top HIV/AIDS drugs worldwide based on revenue 2016-2018 Globally, the top drug for the treatment of HIV/AIDS in 2018 was Genvoya, marketed by Gilead. Genvoya generated over 4.6 billion U.S. dollars in revenue. Truvada, also marketed by Gilead, generated three billion U.S. dollars in revenue. Gilead is the drug manufacturer most specialized in developing drugs for the treatment of HIV/AIDS.
HIV/AIDS cases worldwide

HIV is a virus that attacks the immune system, leading to an increased risk of infections and can lead to death. HIV/AIDS first appeared in global populations in the 1980s. According to current estimates, the prevalence of HIV is highest in low and middle income countries. Swaziland, followed by Lesotho had the highest rates of HIV infections in 2017. The number of new HIV infections yearly is highest among residents of South Africa.

Access to HIV/AIDS treatment

Effective treatment for HIV was not available until the early 1990s. Access to therapy has increased since the early 2000s, and as of 2017 there were almost 22 million people that had access to antiretroviral therapy. Among countries around the world, Uganda, India and Kenya, to name a few, have the lowest rates of access to antiretroviral medications for the treatment of HIV/AIDS. Meanwhile, trends indicate that children living with HIV in Asia or the Pacific have some of the highest rates of access to antiretroviral therapy globally.
Show more

Selected top HIV/AIDS drugs worldwide based on revenue from 2016 to 2018 (in million U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Global HIV/AIDS epidemic
Global HIV/AIDS epidemic

All Information
in one Presentation

Global HIV/AIDS epidemic

Everything On "Global HIV/AIDS epidemic" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Global HIV/AIDS epidemic"
  • Overview
  • Prevalence
  • Other HIV figures
  • AIDS deaths
  • Spending/funding
  • Treatment
The most important statistics
  • HIV and tuberculosis
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statista Accounts: Access All Statistics. Starting from $588 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.